AGP Executive Report
Last update: 2 hours agoMedicine Access: India’s Supreme Court questioned why a 30% trade-margin cap applies only to anti-cancer drugs, citing steep markups on other medicines and medical supplies. It asked the government to propose broader price controls by Oct. 27. Opioid Safety: An Arizona study found the state’s naloxone-prescribing law was followed by a sharp rise in prescriptions—not just for patients taking high-dose opioids, but also for some receiving lower doses. Heart Failure Research: In a phase 2 trial, investigational drug tovinontrine lowered a heart-failure marker in patients with reduced ejection fraction, adding to research into treatments for people already receiving standard care. Health Workforce: Malaysia’s health minister said the government will seek permanent positions for contract pharmacists and dental officers, using a separate hiring quota.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
